Login

Toronto REIT Slated for Battle With Largest Shareholder Over Board

Activist Investor George Armoyan Targets Slate Office After REIT Issues Debentures To Pay for Chicago-Area Building
Slate Office REIT has a deal in place to buy this surburban office building in Chicago that is home to a local Pfizer office. (CoStar)
Slate Office REIT has a deal in place to buy this surburban office building in Chicago that is home to a local Pfizer office. (CoStar)
CoStar News
October 24, 2022 | 9:41 P.M.

Longtime activist investor George Armoyan is unhappy with debentures that a Toronto-based real estate investment trust is issuing as part of a move to buy a suburban Chicago office tower occupied by global pharmaceutical giant Pfizer.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE